affiliation not provided to SSRN
HNSCC, Response prediction, Radiotherapy, ex vivo assay, homologous recombination deficiency (HRD), tumor infiltrating lymphocytes
Tumor Microenvironment, breast cancer, treatment prediction, tumor infiltrating lymphocytes (TILs)
HNSCC, response prediction, radiotherapy, ex vivo assay, homologous recombination deficiency (HRD), tumor infiltrating lymphocytes